Interactions between Mitochondria, ER, and Amyloid
Interactions between Mitochondria, ER, and Amyloid
批准号:
10751909
负责人:
Taylor A. Strope
金额:
$3.63万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-06 至 2028-08-05
关键词:
Abeta synthesisAddressAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease therapeuticAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorAreaAstrocytesAwardBioenergeticsBiological AssayBiologyBrainCRISPR/Cas technologyCareer ChoiceCentrifugationCholesterol EstersCholesterol HomeostasisDataDementiaDiagnosisElectron MicroscopyEndoplasmic ReticulumEnvironmentEnzyme-Linked Immunosorbent AssayEvaluationFellowshipFunctional disorderGenerationsGoalsGrantHumanImpairmentIn SituInduced pluripotent stem cell derived neuronsIntegral Membrane ProteinKansasLigationMedical centerMembraneMentorsMethodsMitochondriaModalityMutationNeurofibrillary TanglesNeuronsOxidative StressPathologicPhospholipid MetabolismPhospholipidsPostdoctoral FellowProductionResearchRoleSamplingSiteTestingTrainingUniversitiesUp-RegulationWestern BlottingWorkamyloid precursor protein processingbeta secretasecalcium metabolismcareercell typedesignexperiencegenome editinginduced pluripotent stem cellinsightmembrane activitymembrane assemblymitochondrial metabolismnew therapeutic targetnon-dementednovelstem cell modeltau Proteins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary and Abstract
Alzheimer’s disease (AD) is the most common form of dementia diagnosed through the presence of tau
tangles and amyloid beta (Aβ) plaques within the brain. Aβ is generated from amyloid precursor protein (APP),
an integral membrane protein. APP and Aβ localize to mitochondria and mitochondrial associated membranes
(MAMs). MAMs are endoplasmic reticulum (ER)-mitochondria contact sites and are associated with altered
function of both the ER and mitochondria. Previous studies have shown that MAM activity directly influences
APP processing into Aβ. We hypothesize that localization of APP at mitochondria and MAMs dictates Aβ
production.
Prior studies indicate APP localization at the mitochondria, ER, and MAMs affects their function, but an
overall mechanism is not understood. Mitochondrial and ER dysfunction are observed in AD. Impaired
mitochondrial bioenergetics, increased oxidative stress, and altered mitochondrial calcium, cholesterol, and
phospholipid metabolism are evident in models of AD. MAMs are known to modulate these functional
modalities between mitochondria and ER, and upregulation of MAMs is observed in AD. This upregulation of
MAM function is hypothesized to drive APP processing into Aβ and disrupt mitochondrial and ER function.
We will test our hypothesis in two aims. We will elucidate the effects of APP localization on Aβ
production and evaluate if MAM function influences localization of APP. We will address how APP and Aβ
production interact with MAM function. We will also evaluate AD and cell-type specific changes between these
relationships. Addressing the relationship between MAMs, APP, and Aβ production will provide novel insights
into their roles in AD pathology.
This F31 award is designed to further Taylor Strope’s career path by complimenting her current training
and developing expertise in new areas. These new areas include genome editing and differentiation of induced
pluripotent stem cells (iPSCs), mitochondrial/ER biology, and APP biology. At the University of Kansas Medical
Center (KUMC), Taylor Strope will work with her mentors, Drs. Wilkins and Swerdlow of the Alzheimer’s
Disease Research Center. The expert mentoring team, strong training environment, and research experience
are imperative for advancing Taylor Strope’s academic career goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金